Apparently the EpiCapture test is undergoing regulatory approvals in the US (not sure about Canada); which could take as long as 1-2 years. A couple studies, involving ~450 men each, have been published.

From what I read, in order to "correctly predict all high grade cancers" the EpiCapture test results must be combined with a man's PSA level, via a proprietary algorithm.

Trinity Biotech (the company who bought the EpiCapture Test start-up company) showed some revenue growth and has improved their net operating loss in their most recent Q3 2024 financial report. Sounds promising, but still a ways to go.
https://www.stocktitan.net/news/TRIB/trinity-biotech-announces-q3-2024-financial-53coj4nfk6qn.html